Gain Therapeutics (GANX) Net Margin (2020 - 2023)
Gain Therapeutics (GANX) posted quarterly Net Margin of 9310.11% for Q1 2023, down 203854.0% year-over-year from N/an in Q1 2022, and up 94.51% quarter-over-quarter from 169620.18% in Q4 2022.
Gain Therapeutics (GANX) Net Margin (2020 - 2023) Analysis & Trends
Gain Therapeutics' Net Margin history runs 4 years deep, the most recent figure standing at 9310.11% for Q1 2023.
- In Q1 2023, Net Margin fell 203854.0% year-over-year to 9310.11%; the TTM figure through Dec 2023 stood at 40878.89% (down 4069113.0% YoY), while the FY2023 annual figure was 40878.89%, down 4069113.0% from the prior year.
- Net Margin for Q1 2023 stood at 9310.11%, up from 169620.18% in the prior quarter.
- The five-year high for Net Margin was 4658.53% in Q2 2021, with the low at 169620.18% in Q4 2022.
- The 4-year median for Net Margin is 10301.26% (2020), against an average of 27227.12%.
- Peak annual rise in Net Margin reached 3923530 bps in 2022, while the deepest fall reached 14310121 bps in 2022.
- Gain Therapeutics' Net Margin stood at 11292.42% in 2020, then plunged by 135 bps to 26518.97% in 2021, then slumped by 540 bps to 169620.18% in 2022, then jumped by 95 bps to 9310.11% in 2023.
- Business Quant data shows GANX's Net Margin at 9310.11% in Q1 2023, 169620.18% in Q4 2022, and 5347.33% in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -539.31% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.90% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 12.74% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -16.51% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -3.12% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 12.09% |
| 10 | Gain Therapeutics | 85.97 Mn | 85.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -9,310.11% |
| Dec 31, 2022 | -169,620.18% |
| Jun 30, 2022 | -5,347.33% |
| Mar 31, 2022 | -7,271.57% |
| Dec 31, 2021 | -26,518.97% |
| Sep 30, 2021 | -17,054.43% |
| Jun 30, 2021 | -4,658.53% |
| Mar 31, 2021 | -46,506.87% |
| Dec 31, 2020 | -11,292.42% |
| Sep 30, 2020 | -11,863.37% |
| Jun 30, 2020 | -8,526.00% |
| Mar 31, 2020 | -8,755.70% |